BWX Technologies (BWXT) Misses Q2 EPS by 2c, Reiterates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BWX Technologies Reports Solid Second Quarter 2018 Results with Strong Revenue Growth
August 6, 2018 4:35 PM EDT2Q18 strong revenue growth of 7%; 2Q18 orders up significantly 2Q18 GAAP EPS of $0.60; 2Q18 non-GAAP EPS of $0.58 Reiterated 2018 non-GAAP EPS guidance of $2.45 to $2.55 despite higher interest expense and integration costs Completed acquisition of Nordion medical isotope business on July 30, 2018
LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) ("BWXT" or the "Company") reported second quarter 2018 revenue of $439 million, a 7.1% increase compared to $410 million in the second quarter of 2017. GAAP net income for the second... More



